Regioselective hydroxylation of steroid hormones by human cytochromes P450

References

• Agrawa V, Choi JH, Giacomini KM, Miller WL. (2010). Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase. Pharmacogenet Genomics 20:611–618
   PubMed Web of Science ®Google Scholar
• Auchus RJ, Lee TC, Miller WL. (1998). Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer. J Biol Chem 273:3158–3165
   PubMed Web of Science ®Google Scholar
• Badawi AF, Cavalieri EL, Rogan EG. (2001). Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16α-hydroxylation of 17β-estradiol. Metabolism 50:1001–1003
   PubMed Web of Science ®Google Scholar
• Cao PR, Bernhardt R. (1999). Interaction of CYP11B1 (cytochrome P-45011β) with CYP11A1 (cytochrome P-450scc) in COS-1 cells. Eur J Biochem 262:720–726
   PubMedGoogle Scholar
• Cheng Q, Sohl CD, Yoshimoto FK, Guengerich FP. (2012). Oxidation of dihydrotestosterone by human cytochromes P450 19A1 and 3A4. J Biol Chem 287:29554–29567
   PubMed Web of Science ®Google Scholar
• Cheng Z, Shu Y, Liu Z, et al. (2000). Role of cytochrome P450 in estradiol metabolism in vitro. Acta Pharmacol Sin 22:148–154
   Web of Science ®Google Scholar
• Choi MH, Skipper PL, Wishnok JS, Tannenbaum SR. (2005). Characterization of testosterone 11β-hydroxylation catalyzed by human liver microsomal cytochromes P450. Drug Metab Dispos 33:714–718
   PubMed Web of Science ®Google Scholar
• Choi SY, Koh KH, Jeong H. (2013). Isoform-specific regulation of cytochromes P450 expression by estradiol and progesterone. Drug Metab Dispos 41:263–269
   PubMed Web of Science ®Google Scholar
• Cribb AE, Knight MJ, Dryer D, et al. (2006). Role of polymorphic human cytochrome P450 enzymes in estrone oxidation. Cancer Epidemiol Biomarkers Prev 15:551–558
   PubMed Web of Science ®Google Scholar
• Deo AK, Bandiera SM. (2008). Identification of human hepatic cytochrome P450 enzymes involved in the biotransformation of cholic and chenodeoxycholic acid. Drug Metab Dispos 36:1983–1991
   PubMed Web of Science ®Google Scholar
• Diczfalusy U, Björkhem I. (2011). Still another activity by the highly promiscuous enzyme CYP3A4: 25-hydroxylation of cholesterol. Lipid Res 52:1447–1449
   PubMed Web of Science ®Google Scholar
• Diczfalusy U, Kanebratt KP, Bredberg E, et al. (2009). 4β-Hydroxycholesterol as an endogenous marker for CYP3A4/5 activity. Stability and half-life of elimination after induction with rifampicin. Br J Clin Pharmacol 67:38–43
   PubMed Web of Science ®Google Scholar
• Diczfalusy U, Nylén H, Elander P, Bertilsson L. (2011). 4β-Hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans. Br J Clin Pharmacol 71:183–189
   PubMed Web of Science ®Google Scholar
• Enberg U, Volpe C, Hamberger B. (2003). New aspects on primary aldosteronism. Neurochem Res 28:327–332
   PubMed Web of Science ®Google Scholar
• Flück CE, Miller WL, Auchus RJ. (2003). The 17,20-lyase activity of cytochrome p450c17 from human fetal testis favors the Δ5 steroidogenic pathway. J Clin Endocrinol Metab 88:3762–3766
   PubMed Web of Science ®Google Scholar
• Gillam EM, Baba T, Kim B-R, et al. (1993). Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme. Arch Biochem Biophys 305:123–131
   PubMed Web of Science ®Google Scholar
• Gomes LG, Huang N, Agrawal V, et al. (2009). Extraadrenal 21-hydroxylation by CYP2C19 and CYP3A4: Effect on 21-hydroxylase deficiency. J Clin Endocrinol Metab 94:89–95
   PubMed Web of Science ®Google Scholar
• Hiroi T, Kishimoto W, Cho T, et al. (2001). Progesterone oxidation by cytochrome P450 2D isoforms in the brain. Endocrinology 142:3901–3908
   PubMed Web of Science ®Google Scholar
• Honda A, Miyazaki T, Ikegami T, et al. (2011). Cholesterol 25-hydroxylation activity of CYP3A. J Lipid Res 52:1509–1516
   PubMed Web of Science ®Google Scholar
• Imai T, Globerman H, Gertner JM, et al. (1993). Expression and purification of functional human 17α-hydroxylase/17,20-lyase (P450c17) in Escherichia coli. Use of this system for study of a novel form of combined 17α-hydroxylase/17,20-lyase deficiency. J Biol Chem 268:19681–19689
   PubMed Web of Science ®Google Scholar
• Imaoka S, Yamada T, Hiroi T, et al. (1996). Multiple forms of human P450 expressed in Saccharomyces cerevisiae. Systematic characterization and comparison with those of the rat. Biochem Pharmacol 51:1041–1050
   PubMed Web of Science ®Google Scholar
• Isoherranen N, Thummel KE. (2013). Drug metabolism and transport during pregnancy: How does drug disposition change during pregnancy and what are the mechanisms that cause such changes? Drug Metab Dispos 41:256–262
   PubMed Web of Science ®Google Scholar
• Jansson I, Stoilov I, Sarfarazi M, Schenkman JB. (2001). Effect of two mutations of human CYP1B1, G61E and R469W, on stability and endogenous steroid substrate metabolism. Pharmacogenetics 11:793–801
   PubMedGoogle Scholar
• Kagawa N, Hori H, Waterman MR, Yoshioka S. (2004). Characterization of stable human aromatase expressed in E. coli. Steroids 69:235–243
   PubMed Web of Science ®Google Scholar
• Katagiri M, Kagawa N, Waterman MR. (1995). The role of cytochrome b5 in the biosynthesis of androgens by human P450c17. Arch Biochem Biophys 317:343–347
   PubMed Web of Science ®Google Scholar
• Kellis JT Jr, Vickery LE. (1987). Purification and characterization of human placental aromatase cytochrome P-450. J Biol Chem 262:4413–4420
   PubMed Web of Science ®Google Scholar
• Kenworthy KE, Clarke SE, Andrews J, Houston JB. (2001). Multisite kinetic models for CYP3A4: Simultaneous activation and inhibition of diazepam and testosterone metabolism. Drug Metab Dispos 29:1644–1651
   PubMed Web of Science ®Google Scholar
• Kerlan V, Dreano Y, Bercovici JP, et al. (1992). Nature of cytochromes P450 involved in the 2-/4-hydroxylations of estradiol in human liver microsomes. Biochem Pharmacol 44:1745–1756
   PubMed Web of Science ®Google Scholar
• Kishimoto W, Hiroi T, Shiraishi M, et al. (2004). Cytochrome P450 2D catalyze steroid 21-hydroxylation in the brain. Endocrinology 145:699–705
   PubMed Web of Science ®Google Scholar
• Kohalmy K, Tamási V, Kóbori L, et al. (2007). Dehydroepiandrosterone induces human CYP2B6 through the constitutive androstane receptor. Drug Metab Dispos 35:1495–1501
   PubMed Web of Science ®Google Scholar
• Lee AJ, Cai MX, Thomas PE, et al. (2003a). Characterization of the oxidative metabolites of 17β-estradiol and estrone formed by 15 selectively expressed human cytochrome P450 isoforms. Endocrinology 144:3382–3398
   PubMed Web of Science ®Google Scholar
• Lee AJ, Conney AH, Zhu BT. (2003b). Human cytochrome P450 3A7 has a distinct high catalytic activity for the 16α-hydroxylation of estrone but not 17β-estradiol. Cancer Res 63:6532–6536
   PubMed Web of Science ®Google Scholar
• Lee SJ, Goldstein JA. (2012). Comparison of CYP3A4 and CYP3A5: The effects of cytochrome b5 and NADPH-cytochrome P450 reductase on testosterone hydroxylation activities. Drug Metab Pharmacokinet 27:663–667
   PubMed Web of Science ®Google Scholar
• Lee-Robichaud P, Wright JN, Akhtar ME, Akhtar M. (1995). Modulation of the activity of human 17α-hydroxylase-17,20-lyase (CYP17) by cytochrome b5: Endocrinological and mechanistic implications. Biochem J 308:901–908
   PubMed Web of Science ®Google Scholar
• Lu F, Zahid M, Saeed M, et al. (2007). Estrogen metabolism and formation of estrogen-DNA adducts in estradiol-treated MCF-10F cells. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin induction and catechol-O-methyltransferase inhibition. J Steroid Biochem Mol Biol 105:150–158
   PubMed Web of Science ®Google Scholar
• Mäenpää J, Pelkonen O, Cresteil T, Rane A. (1993). The role of cytochrome P450 3A (CYP3A) isoform(s) in oxidative metabolism of testosterone and benzphetamine in human adult and fetal liver. J Steroid Biochem Mol Biol 44:61–67
   PubMed Web of Science ®Google Scholar
• Masimirembwa CM, Otter C, Berg M, et al. (1999). Heterologous expression and kinetic characterization of human cytochromes P-450: Validation of a pharmaceutical tool for drug metabolism research. Drug Metab Dispos 27:1117–1122
   PubMed Web of Science ®Google Scholar
• Miller KK, Cai J, Ripp SL, et al. (2004). Stereo- and regioselectivity account for the diversity of dehydroepiandrosterone (DHEA) metabolites produced by liver microsomal cytochromes P450. Drug Metab Dispos 32:305–313
   PubMed Web of Science ®Google Scholar
• Miyazaki M, Nakamura K, Fujita Y, et al. (2008). Defective activity of recombinant cytochromes P450 3A4.2 and 3A4.16 in oxidation of midazolam, nifedipine, and testosterone. Drug Metab Dispos 36:2287–2291
   PubMed Web of Science ®Google Scholar
• Monostory K, Dvorak Z. (2011). Steroid regulation of drug-metabolizing cytochromes P450. Curr Drug Metab 12:154–172
   PubMed Web of Science ®Google Scholar
• Mulatero P, Curnow KM, Aupetit-Faisant B, et al. (1998). Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol. J Clin Endocrinol Metab 83:3996–4001
   PubMed Web of Science ®Google Scholar
• Nakamura H, Nakasa H, Ishii I, et al. (2002). Effects of endogenous steroids on CYP3A4-mediated drug metabolism by human liver microsomes. Drug Metab Dispos 30:534–540
   PubMed Web of Science ®Google Scholar
• Nakamura H, Torimoto N, Ishii I, et al. (2003). CYP3A4 and CYP3A7-mediated carbamazepine 10,11-epoxidation are activated by differential endogenous steroids. Drug Metab Dispos 31:432–438
   PubMed Web of Science ®Google Scholar
• Niwa T, Hiroi T, Tsuzuki D, et al. (2004). Effect of genetic polymorphism on the metabolism of endogenous neuroactive substances, progesterone and p-tyramine, catalyzed by CYP2D6. Mol Brain Res 129:117–123
   PubMedGoogle Scholar
• Niwa T, Imamura H, Katagiri M. (2012). Inhibition of human steroidogenic cytochrome P450 c17 by 21-hydroxypregnenolone and related steroid hormones. Biol Pharm Bull 35:1594–1597
   PubMed Web of Science ®Google Scholar
• Niwa T, Kageyama A, Kishimoto K, et al. (2002). Amino acid residues affecting the activities of human cytochrome P450 2C9 and 2C19. Drug Metab Dispos 30:931–936
   PubMed Web of Science ®Google Scholar
• Niwa T, Murayama N, Emoto C, Yamazaki H. (2009a). Comparison of kinetic parameters for drug oxidation rates and substrate inhibition potential mediated by cytochrome P450 3A4 and 3A5. Curr Drug Metab 9:20–33
   Web of Science ®Google Scholar
• Niwa T, Murayama N, Yamazaki H. (2008a). Heterotropic cooperativity in oxidation mediated by cytochrome P450. Curr Drug Metab 9:453–462
   PubMed Web of Science ®Google Scholar
• Niwa T, Murayama N, Yamazaki H. (2009b). Oxidation of endobiotics mediated by xenobiotic-metabolizing forms of human cytochrome P450. Curr Drug Metab 10:700–712
   PubMed Web of Science ®Google Scholar
• Niwa T, Murayama N, Yamazaki H. (2010a). Comparison of cytochrome P450 2D6 and variants in terms of drug oxidation rates and substrate inhibition. Curr Drug Metab 12:412–435
   Web of Science ®Google Scholar
• Niwa T, Murayama N, Yamazaki H. (2010b). Comparison of the contributions of cytochrome P450 3A4 and 3A5 in drug oxidation rates and substrate inhibition. J Health Sci 56:239–256
   Web of Science ®Google Scholar
• Niwa T, Okada K, Hiroi T, et al. (2008b). Effect of psychotropic drugs on the 21-hydroxylation of neurosteroids, progesterone and allopregnanolone, catalyzed by rat CYP2D4 and human CYP2D6 in the brain. Biol Pharm Bull 31:348–351
   PubMed Web of Science ®Google Scholar
• Niwa T, Shiraga T, Yamasaki S, et al. (2003). In vitro activation of 7-benzyloxyresorufin O-debenzylation and nifedipine oxidation in human liver microsomes. Xenobiotica 33:717–729
   PubMed Web of Science ®Google Scholar
• Niwa T, Yabusaki Y, Honma K, et al. (1998). Contribution of human hepatic cytochrome P450 isoforms to regioselective hydroxylation of steroid hormones. Xenobiotica 28:539–547
   PubMed Web of Science ®Google Scholar
• Niwa T, Yamazaki H. (2011). Comparison of cytochrome P450 2C subfamily members in terms of drug oxidation rates and substrate inhibition. Curr Drug Metab 13:1145–1159
   Web of Science ®Google Scholar
• Niwa T, Yasumura M, Murayama N, Yamazaki H. (2014). Comparison of catalytic properties of cytochromes P450 3A4 and 3A5 by molecular docking simulation. Drug Metab Lett 8:43–50
   PubMedGoogle Scholar
• Ohmori S, Fujiki N, Nakasa H, et al. (1998). Steroid hydroxylation by human fetal CYP3A7 and human NADPH-cytochrome P450 reductase coexpressed in insect cells using baculovirus. Res Commun Mol Pathol Pharmacol 100:15–28
   PubMed Web of Science ®Google Scholar
• Paracchini V, Pedotti P, Raimondi S, et al. (2005). A common CYP1B1 polymorphism is associated with 2-OHE1/16-OHE1 urinary estrone ratio. Clin Chem Lab Med 43:702–706
   PubMed Web of Science ®Google Scholar
• Papageorgiou I, Grepper S, Unadkat JD. (2013). Induction of hepatic CYP3A enzymes by pregnancy-related hormones: Studies in human hepatocytes and hepatic cell lines. Drug Metab Dispos 41:281–290
   PubMed Web of Science ®Google Scholar
• Peng CC, Templeton I, Thummel KE, et al. (2011). Evaluation of 6β-hydroxycortisol, 6β-hydroxycortisone, and a combination of the two as endogenous probes for inhibition of CYP3A4 in vivo. Clin Pharmacol Ther 89:888–895
   PubMed Web of Science ®Google Scholar
• Pikuleva IA. (2006a). Cytochrome P450s and cholesterol homeostasis. Pharmacol Ther 112:761–773
   PubMed Web of Science ®Google Scholar
• Pikuleva IA. (2006b). Cholesterol-metabolizing cytochromes P450. Drug Metab Dispos 34:513–520
   PubMed Web of Science ®Google Scholar
• Pikuleva IA, Waterman MR. (2013). Cytochromes p450: Roles in diseases. J Biol Chem 288:17091–17098
   PubMed Web of Science ®Google Scholar
• Rais N, Hussain A, Chawla YK, Kohli KK. (2013). Association between urinary 6β-hydroxycortisol/cortisol ratio and CYP3A5 genotypes in a normotensive population. Exp Ther Med 5:527–532
   Web of Science ®Google Scholar
• Rendic S. (2002). Summary of information on human CYP enzymes: Human P450 metabolism data. Drug Metab Rev 34:83–448
   PubMed Web of Science ®Google Scholar
• Rendic S, Di Carlo FJ. (1997). Human cytochrome P450 enzymes: A status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metab Rev 29:413–580
   PubMed Web of Science ®Google Scholar
• Rendic S, Nolteernsting E, Schänzer W. (1999). Metabolism of anabolic steroids by recombinant human cytochrome P450 enzymes. Gas chromatographic-mass spectrometric determination of metabolites. J Chromatogr B Biomed Sci Appl 26: 73–83
   Google Scholar
• Russo J, Hasan Lareef M, Balogh G, et al. (2003). Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells. J Steroid Biochem Mol Biol 87:1–25
   PubMed Web of Science ®Google Scholar
• Shackleton CH. (2012). Role of a disordered steroid metabolome in the elucidation of sterol and steroid biosynthesis. Lipids 47:1–12
   PubMed Web of Science ®Google Scholar
• Schwarz D, Kisselev P, Schunck WH, et al. (2000). Allelic variants of human cytochrome P450 1A1 (CYP1A1): Effect of T461N and I462V substitutions on steroid hydroxylase specificity. Pharmacogenetics 10:519–530
   PubMedGoogle Scholar
• Shet MS, Fisher CW, Tremblay Y, et al. (2007). Comparison of the 17α-hydroxylase/C17,20-lyase activities of porcine, guinea pig and bovine P450c17 using purified recombinant fusion proteins containing P450c17 linked to NADPH-P450 reductase. Drug Metab Rev 39:289–307
   PubMed Web of Science ®Google Scholar
• Shimada T, Yamazaki H, Mimura M, et al. (1994). Interindividual variation in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414–423
   PubMed Web of Science ®Google Scholar
• Shimada T, Watanabe J, Kawajiri K, et al. (1999). Catalytic properties of polymorphic human cytochrome P450 1B1 variants. Carcinogenesis 20:1607–1613
   PubMed Web of Science ®Google Scholar
• Shinkyo R, Guengerich FP. (2011). Inhibition of human cytochrome P450 3A4 by cholesterol. J Biol Chem 286:18426–18433
   PubMed Web of Science ®Google Scholar
• Sohl CD, Guengerich FP. (2010). Kinetic analysis of the three-step steroid aromatase reaction of human cytochrome P450 19A1. J Biol Chem 285:17734–17743
   PubMed Web of Science ®Google Scholar
• Spink DC, Spink BC, Cao JQ, et al. (1998). Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells. Carcinogenesis 19:291–298
   PubMed Web of Science ®Google Scholar
• Stevens JC, Hines RN, Gu C, et al. (2003). Developmental expression of the major human hepatic CYP3A enzymes. J Pharmacol Exp Ther 307:573–582
   PubMed Web of Science ®Google Scholar
• Storbeck KH, Swart P, Africander D, et al. (2011). 16α-Hydroxyprogesterone: Origin, biosynthesis and receptor interaction. Mol Cell Endocrinol 336:92–101
   PubMed Web of Science ®Google Scholar
• Sugimoto H, Shiro Y. (2012). Diversity and substrate specificity in the structures of steroidogenic cytochrome P450 enzymes. Biol Pharm Bull 35:818–823
   PubMed Web of Science ®Google Scholar
• Swinney DC. (1990). Progesterone metabolism in hepatic microsomes. Effect of the cytochrome P-450 inhibitor, ketoconazole, and the NADPH 5α-reductase inhibitor, 4-MA, upon the metabolic profile in human, monkey, dog, and rat. Drug Metab Dispos 18:859–865
   PubMed Web of Science ®Google Scholar
• Thomas JL, Duax WL, Addlagatta A, et al. (2003). Structure/function relationships responsible for coenzyme specificity and the isomerase activity of human type 1,3-β-hydroxysteroid dehydrogenase/isomerase. J Biol Chem 278:35483–35490
   PubMed Web of Science ®Google Scholar
• Usmani KA, Cho TM, Rose RL, Hodgson E. (2006). Inhibition of the human liver microsomal and human cytochrome P450 1A2 and 3A4 metabolism of estradiol by deployment-related and other chemicals. Drug Metab Dispos 34:1606–1614
   PubMed Web of Science ®Google Scholar
• Williams JA, Ring BJ, Cantrell VE, et al. (2002). Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7. Drug Metab Dispos 30:883–891
   PubMed Web of Science ®Google Scholar
• Wu DA, Chung BC. (1991). Mutations of P450c21 (steroid 21-hydroxylase) at Cys428, Val281, and Ser268 result in complete, partial, or no loss of enzymatic activity, respectively. J Clin Invest 88:519–523
   PubMed Web of Science ®Google Scholar
• Yamazaki H, Nakamura M, Komatsu T, et al. (2002). Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli. Protein Expr Purif 24:329–337
   PubMed Web of Science ®Google Scholar
• Yamazaki H, Shaw PM, Guengerich FP, Shimada T. (1998). Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes. Chem Res Toxicol 11:659–665
   PubMed Web of Science ®Google Scholar
• Yamazaki H, Shimada T. (1997). Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes. Arch Biochem Biophys 346:161–169
   PubMed Web of Science ®Google Scholar
• Zhu BT, Conney AH. (1998). Functional role of estrogen metabolism in target cells: Review and perspectives. Carcinogenesis 19:1–27
   PubMed Web of Science ®Google Scholar